- Home
- PRTA vs PGY Comparison
PRTA vs PGY Comparison
Compare PRTA & PGY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PRTA
- PGY
- Stock Information
- Founded
- PRTA 2012
- PGY 2016
- Country
- PRTA Ireland
- PGY United States
- Employees
- PRTA N/A
- PGY N/A
- Industry
- PRTA Biotechnology: Pharmaceutical Preparations
- PGY Finance: Consumer Services
- Sector
- PRTA Health Care
- PGY Finance
- Exchange
- PRTA Nasdaq
- PGY Nasdaq
- Market Cap
- PRTA 809.8M
- PGY 863.7M
- IPO Year
- PRTA N/A
- PGY N/A
- Fundamental
- Price
- PRTA $6.58
- PGY $23.48
- Analyst Decision
- PRTA Buy
- PGY Strong Buy
- Analyst Count
- PRTA 9
- PGY 9
- Target Price
- PRTA $27.67
- PGY $23.61
- AVG Volume (30 Days)
- PRTA 1.7M
- PGY 2.5M
- Earning Date
- PRTA 08-07-2025
- PGY 08-07-2025
- Dividend Yield
- PRTA N/A
- PGY N/A
- EPS Growth
- PRTA N/A
- PGY N/A
- EPS
- PRTA N/A
- PGY N/A
- Revenue
- PRTA $137,935,000.00
- PGY $1,076,961,000.00
- Revenue This Year
- PRTA N/A
- PGY $20.61
- Revenue Next Year
- PRTA $119.20
- PGY $13.33
- P/E Ratio
- PRTA N/A
- PGY N/A
- Revenue Growth
- PRTA 54.55
- PGY 23.69
- 52 Week Low
- PRTA $4.32
- PGY $8.20
- 52 Week High
- PRTA $25.42
- PGY $23.57
- Technical
- Relative Strength Index (RSI)
- PRTA 59.96
- PGY 71.58
- Support Level
- PRTA $5.96
- PGY $21.11
- Resistance Level
- PRTA $6.59
- PGY $23.13
- Average True Range (ATR)
- PRTA 0.38
- PGY 1.21
- MACD
- PRTA 0.15
- PGY 0.10
- Stochastic Oscillator
- PRTA 83.93
- PGY 85.16
About PRTA Prothena Corporation plc
Prothena Corp PLC is a biotechnology company that focuses on protein dysregulation and a pipeline of investigational therapeutics with the potential to change the course of devastating rare neurodegenerative and peripheral amyloid diseases. The company's clinical pipeline of antibody-based product candidates targets a range of indications, including Amyloid Light-chain (AL) amyloidosis (NEOD001), Parkinson's disease and other related synucleinopathies (PRX002), and inflammatory diseases, including psoriasis and psoriatic arthritis (PRX003) and ATTR amyloidosis (PRX004).
About PGY Pagaya Technologies Ltd.
Pagaya Technologies Ltd is a financial technology company working to reshape the lending marketplace by using machine learning, data analytics, and sophisticated AI-driven credit and analysis technology. It was built to provide a comprehensive solution to enable the credit industry to deliver customers a positive experience while simultaneously enhancing the broader credit ecosystem. Its proprietary API seamlessly integrates into its next-gen infrastructure network of partners to deliver a premium customer user experience and greater access to credit. The company generates majority of its revenue from United States.